20 set
|
Alnylam Pharmaceuticals
|
Italia
20 set
Alnylam Pharmaceuticals
Italia
Our client is Alnylam Pharmaceuticals (Nasdaq: ALNY), a leading biopharmaceutical company that has pioneered the translation of RNA interference (RNAi) into a new class of innovative medicines, with the potential to transform the lives of patients affected by rare and more prevalent diseases.
Founded in 2002 and built on Nobel Prize-winning science, Alnylam has led the RNAi Revolution by developing clinically validated therapies that target diseases at their genetic source,
📌 Area Sales Manager - Central Italy (Italia)
🏢 Alnylam Pharmaceuticals
📍 Italia